A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary

References

• Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20:593–621.
   PubMed Web of Science ®Google Scholar
• Treviño M, Areses P, Peñalver MD, et al. Susceptibility trends of Bacteroides fragilis group and characterization of carbapenemase-producing strains by automated REP-PCR and MALDI-TOF. Anaerobe. 2012;18:37–43.
   PubMed Web of Science ®Google Scholar
• Nagy E, Urbán E, Nord CE. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17:371–379.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 23rd Informational Supplement. CLSI document M100-S23. Wayne (PA): CLSI; 2013.
   Google Scholar
• Brook I, Wexler HM, Goldstein EJC. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev. 2013;26:526–546.
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Walkty AJ, Adam HJ, et al. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010–2011: CANWARD surveillance study. Antimicrob Agents Chemother. 2012;56:1247–1252.
   PubMed Web of Science ®Google Scholar
• Cuchural GJ, Tally FP, Jacobus NV, et al. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother. 1988;32:717–722.
   PubMed Web of Science ®Google Scholar
• Fenyvesi VS, Urban E, Bartha N, et al. Use of MALDI-TOF/MS for routine detection of cfiA gene-positive Bacteroides fragilis strains. Int J Antimicrob Agents. 2014;44:469–476.
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical Breakpoints v. 7. 1; 2017.
   Google Scholar
• Eitel Z, Sóki J, Urbán E, et al. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe. 2013;21:43–49.
   PubMed Web of Science ®Google Scholar
• Wybo I, van den Bossche D, Soetens O, et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother. 2014;69:155–161.
   PubMed Web of Science ®Google Scholar
• Nagy E, Szőke I, Gacs M, et al. Antibiotic susceptibility of Bacteroides fragilis group strains in Hungary. Anaerobe. 1995;1:269–274.
   PubMed Web of Science ®Google Scholar
• Snydman DR, Jacobus NV, McDermott LA, et al. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009. Anaerobe. 2017;43:21–26.
   PubMed Web of Science ®Google Scholar
• Liu CY, Huang YT, Liao CH, et al. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenem. Antimicrob Agents Chemother. 2008;52:3161–3168.
   PubMed Web of Science ®Google Scholar
• Fernández-Canigia L, Litterio M, Legaria MC, et al. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina. Antimicrob Agents Chemother. 2012;56:1309–1314.
   PubMed Web of Science ®Google Scholar
• Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother. 2007;51:1646–1655.
   Web of Science ®Google Scholar
• Soki J, Edwards R, Hedberg M, et al. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis from a European antibiotic susceptibility survey. Int J Antimicrob Agents. 2006;28:497–502.
   PubMed Web of Science ®Google Scholar
• Podglajen I, Breuil J, Casin I, et al. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol. 1995;177:5270–5275.
   PubMed Web of Science ®Google Scholar
• Yamazoe K, Kato N, Kato H, et al. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob Agents Chemother. 1999;43:2808–2810.
   PubMed Web of Science ®Google Scholar
• Sóki J, Urbán E, Szőke I, et al. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates in Bacteroides species in Hungary. J Med Microbiol. 2004;53:413–430.
   PubMedGoogle Scholar
• Jeverica S, Kolenc U, Mueller-Premru M, et al. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015. Anaerobe. 2017;47:64–69.
   PubMed Web of Science ®Google Scholar
• Jamal W, Al Hashem G, Rotimi VO. Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data. Anaerobe. 2015;31:25–30.
   PubMed Web of Science ®Google Scholar
• Nitzan O, Kennes Y, Colodner R, et al. Chloramphenicol use and susceptibility patterns in Israel: a national survey. Isr Med Assoc J. 2015;17:27–31.
   PubMed Web of Science ®Google Scholar
• Rogers MB, Parker AC, Smith CJ. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler Class A β-lactamases. Antimicrob Agents Chemother. 1993;37:2391–2400.
   PubMed Web of Science ®Google Scholar
• Bartha NA, Sóki J, Urbán E. Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents. 2011;38:522–525.
   PubMed Web of Science ®Google Scholar
• Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe. 2015;31:4–10.
   PubMed Web of Science ®Google Scholar